Lords Chloro Alkali Q2 FY27: PAT flat YoY at ₹9 Cr as margins compress on costlier inputs
PAT -0.25% YoY · revenue +17.35% · margins compressing
₹115.4 Cr
+17.35% YoY
₹9.02 Cr
-0.25% YoY
7.81%
-1.2pp YoY
₹3.15
Lords Chloro Alkali's standalone revenue from operations rose 17.3% YoY to ₹115.40 Cr (+8.5% QoQ from ₹106.35 Cr) in Q2 FY27, but PAT was essentially flat YoY at ₹9.02 Cr (-0.3%) and fell 39.7% QoQ from Q1's ₹14.95 Cr — a sharp deceleration from the 43.16% YoY PAT growth the company reported for Q1 FY27. Operating margin compressed to 16.2% from 18.98% a year ago and 21.26% last quarter; net margin fell to 7.81% from 8.97% YoY and 14.03% QoQ.
Q2 FY-2027 vs prior quarters
The squeeze sits on the raw-materials line: cost of raw materials consumed rose to 31.8% of revenue versus 27.2% a year ago and 28.9% last quarter, even as power and fuel costs — the company's other major input — eased to 32.7% of revenue from 39.9% YoY and 40.3% QoQ. PBT itself fell 16.6% YoY to ₹11.78 Cr; PAT held up only because the effective tax rate dropped to 23.5% from 36.0% a year ago, aided by a ₹0.61 Cr current-tax credit this quarter versus a ₹1.31 Cr current-tax charge a year ago — without that tax relief, YoY profit would have tracked the PBT decline.
The stock went into the print at ₹136.51, down 1.8% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
EPS (basic) ₹3.15 vs ₹5.22 in Q1 FY27 and ₹3.59 in Q2 FY26
Management is optimistic about the demand environment for FY27, expecting continued positive momentum in caustic soda realizations driven by strong domestic demand and global commodity trends. They are focused on operational excellence, further energy cost reduction through renewable initiatives, and disciplined capita
— This quarter: missed
Management's Q4 FY26 commentary had guided to margin stability from a 21 MW solar plant commissioning by mid-June 2026; the company instead commissioned a smaller 14.5 MW plant on September 2, 2026 — short of the guided capacity and about 2.5 months late — and this quarter's margin compression shows the promised cost relief has not yet come through. No analyst or street estimates for this quarter turned up in a public search, so the print can't be benchmarked against consensus; no standalone management press release was available to cross-check against the numbers. Results are standalone only (no consolidated statement filed), un-audited, and carry a clean limited-review report with no exceptional items in either period.
W1
Solar capacity build-out beyond the 14.5 MW commissioned Sep 2, 2026 against the 21 MW guided — whether the gap closes and power-cost savings show up in Q3 FY27
W2
Raw material cost ratio (31.8% of revenue this quarter vs 27.2% a year ago) — whether input-cost pressure eases or continues to drive margin compression
W3
Effective tax rate normalisation — this quarter's 23.5% rate included a ₹0.61 Cr current-tax credit; watch for reversion toward the 23-36% range seen over the past year
Filing figures are in ₹ Lakh (cross-checked against DB comparison figures, e.g. Q1 FY27 revenue ₹10,634.64 Lakh = ₹106.35 Cr); all values above converted to ₹ Crore. Standalone statement only — no consolidated section (single Ind AS 108 segment, chloro-alkali). No exceptional items in current or comparative periods. Un-audited, clean limited-review report.
Volume growth, cost control mask caustic margin collapse, QoQ PAT -40%
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
21 MW solar commissioned on time (✓). Caustic soda demand guidance overstated in FY26 calls; realizations worse than implied. Revenue target (INR 550 Cr) reasonable given new plant mid-July, but execution risk high.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Volume growth and renewable energy execution demonstrate operational competence, but caustic soda realizations collapsed to worst quarter in long time and PAT fell 40% QoQ despite steady revenue. Cost inflation (raw materials up INR 6 Cr, labor INR 8 Cr) overwhelmed renewable/efficiency gains. Near-term commodity headwinds dominate; long-term (2024-2026) diversification into specialty chemicals and renewable margin support offer upside if execution stays on track.
₹115.4 Cr
Revenue · +17.3% YoY₹9 Cr
Reported PAT · −0.3% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Highest revenue achieved, INR 115 Cr vs Q2 FY26 INR 100 Cr
METDelivered Q2 FY27 revenue INR 115.4 Cr, actual YoY growth 17.3%, mgmt cited 15% growth
Caustic soda volumes 23,000 tons, up 9% YoY vs Q2 FY26
METQ2 FY26 volume 21,000 tons, Q2 FY27 23,000 tons = 9.5% growth
Similar H1 FY27 numbers to H1 FY26 despite lower realizations
METH1 FY27 revenue ~INR 222 Cr claimed, but H1 FY26 was 'about INR 200 Cr'. Margin compression evident.
Power cost savings INR 5 Cr QoQ due to 21 MW solar commissioned
METPower & fuel INR 37.79 Cr (down from INR 42.79 implied), renewable energy now 40% of consumption (47 MW operational)
Caustic realizations improved to negative 1,000-0 (Alwar region)
MISSManagement acknowledged caustic 'worst quarter in long time', realizations down QoQ from INR 4-5 Cr to lower despite same volumes
Earnings quality
What changed since the last call
Caustic realizations pressure escalates
DowngradeFY26 calls: expected positive caustic momentum. Q2 FY27: worst quarter in long time. Chlorine also pressured until new entrants' PVC plants come online (2-3 years).
Renewable energy 40% achieved, 70%-80% target new
Upgrade21 MW solar commissioned (vs mid-June target), 47 MW DC group captive now operational. New 70%-80% target by 2025-26 if Rajasthan policy holds (dependent on contract finalization).
CPW emerges as bright spot, 40% volume growth
NewNot called out in prior calls. Now 20%-25% income target in 5 years. Paraffin oil cost spike actually benefiting CPW economics; price upped significantly.
FY27 revenue guidance INR 550 Cr, detailed capex roadmap
NewFirst specific FY27 full-year target. Capex INR 315 Cr (INR 150 done, INR 165 by July). Execution on time matters for INR 550 Cr delivery.
The Q&A
Analysts pressed hard on caustic realization cliff, raw material inflation, and profitability decline QoQ. Saket Kapoor (main interrogator) challenged margin math and sought tonnage clarity. Management held firm on cost control narrative, blamed war-induced paraffin inflation, and deferred ECU details to CFO. Tone: defensive but factual.
5-year scale & product mix — Prisha Shah, Shah Family Office
AnsweredINR 550 Cr revenue next year with new plant by July (9 months sales). 360T capacity by July, 500T post-expansion. 20%-25% CPW (specialty), rest caustic. Free cash flow INR 80+ Cr annually. Renewable 70%-80% target.
Caustic export-import dynamics — Saket Kapoor, Kapoor and Company
AnsweredIndia net exporter 6M→8M (Reliance), Adani ~10M. Domestic + global 5% YoY growth. European capacity shutting down. 2 new plants coming. Reliance, Adani setting up depots in Europe for PVC.
Chlorine realization pressure — Saket Kapoor, Kapoor and Company
PartialAlwar region negative 2,000 to 0 (vs Gujarat negative 2,000). Competitive advantage from fewer local players. When Reliance/Adani come in, chlorine goes to PVC, improving market. US market chlorine = caustic soda equals pricing. India lagging but will develop.
Profitability Q-o-Q drivers — Saket Kapoor, Kapoor and Company
AnsweredEmployee benefits up INR 8 Cr (half-yearly payout, Diwali bonus). Raw materials up INR 6 Cr (paraffin oil, war spillover). Power-fuel down INR 5 Cr (renewable savings). Net INR 9 Cr loss in profit. Caustic realizations also down Q-o-Q significantly.
Caustic tonnage vs realization — Saket Kapoor, Kapoor and Company
PartialQ2 tonnage 23,300 (highest for caustic lye, vs Q1 19,953 tons). ECU not available on call; CFO will provide post-call details.
CPW product economics — Saket Kapoor, Kapoor and Company
Answered~150T open market, 100T captive chlorine use. Initially planned to avoid selling negative chlorine. Now benefit due to paraffin oil spike (price of CPW up significantly). Pricing dependent on paraffin oil and CPW market rates.
TPW EBITDA margin — Saket Kapoor, Kapoor and Company
PartialStrong EBITDA but depends on paraffin oil + CPW price (0%-10% to 20% range). CPW market concentrated in New Delhi and north India. Availability limited, prices volatile.
Caustic soda pricing strategy — Mohil Shah, Etica Wealth
AnsweredRealization improved since Q1 (worst quarter in long time). Regional advantage: away from Gujarat ports. Pricing strategy: import-export parity (INR 32,000-33,000 at port), Alwar/north INR 36,000-37,000 (freight difference of INR 4,000-5,000).
Caustic demand growth drivers — Mohil Shah, Etica Wealth
AnsweredCurrent 300T production, 360T by July, 500T post-expansion. Flakes (100+ tons) can reach further, lower freight. Diversification into specialty chemicals. Cost efficiency improvements offset commodity cycles.
Renewable energy operations — Shruti Sharma, Sharda Family Office
Answered40% of energy from renewable (started Oct). Target 70%-80% by 2025-26. Rajasthan policy allows 25% contract renewable. Other states limited. Forward-looking dependent on law changes.
Wind-solar project status — Shruti Sharma, Sharda Family Office
AnsweredAlready receiving power since last year. Very much part of results. 70%-80% renewable possible due to Rajasthan 25% contract policy.
Battery energy storage — Shailen Shah, Shah Family Office
Answered1.45 MW BESS, small and insignificant legally mandated. Won't have real impact on consumption or results. Rajasthan only state requiring 5% BESS for renewables.
BESS future plans — Shailen Shah, Shah Family Office
AnsweredYes, 1.45 MW BESS in current project. BESS just a storage device, not a significant electricity generator. Won't invest heavily until pricing falls and use case emerges.
Caustic capacity expansion timeline — Shailen Shah, Shah Family Office
Answered300T→360T by July next year. Second electrolyzer (120-140T) to reach 500T. Investment INR 140-150 Cr. Will analyze specialty vs commodity expansion; whichever comes first.
Capex funding sources — Shailen Shah, Shah Family Office
AnsweredYes. Internal accruals from July onwards will generate INR 80+ Cr free cash flow annually. Can fund through equity-debt mix or internal accruals.
Remuneration policy — Ruchit Shah, Individual Investor
AnsweredEarlier 4%, 5%, 6%, capped at 4%. Shareholders & board approved. Trajectory changed since 2022; now reducing incentives as profitability risen. Reduced bonus payable significantly.
Remuneration structure — Ruchit Shah, Individual Investor
PartialExact policy available post-call. Reduced going forward. Bonus payable reduced significantly. Board approved. Fixed component focus increased.
Guidance
FY27 INR 550 Cr (next year, new plant 9-month sales)
MediumAssumes new 360T electrolyzer operational by July, 9 months of sales. Achievable if commodity prices stabilize and execution on time. Implies Q3-Q4 growth vs soft Q2.
Quarterly EBITDA INR 15-20 Cr post-July 2026
MediumConservative estimate even on lower caustic realizations. Implies renewal power cost savings and operational leverage. Dependent on raw material cost stabilization.
Renewable energy power cost INR 2 (vs grid INR 8.3, group captive INR 4.50)
High47 MW operational. Target 70%-80% renewable by 2025-26 if Rajasthan law allows 25% contract demand.
INR 315 Cr total capex plan (INR 150 done, INR 165 by July 2026)
HighIncremental electrolyzer 360T by July (part of INR 165 remaining). Second electrolyzer 120-140T by Mar 2027 (INR 140-150 Cr additional, post-July capex).
Risks the call surfaced
Caustic soda commodity exposure
HighCaustic realizations collapsed Q-o-Q to worst quarter in long time. Indian caustic a net exporter (competition from Reliance expansion 6M→8M, Adani 10M). New players Reliance/Adani setting up European depots, compressing global pricing.
Raw material cost inflation
HighParaffin oil cost surge INR 6 Cr (US-Iran tensions causing commodity spikes). Sulfuric acid also up. War-linked inflation may persist, pressuring margins on caustic and CPW products.
Capex execution and funding risk
MediumINR 315 Cr capex plan (INR 165 Cr remaining by July 2026) required to hit INR 550 Cr FY27 revenue and 360T capacity. Delays could push revenue into FY28. Second electrolyzer (INR 140-150 Cr) for 500T capacity timeline uncertain.
New competition from large players
MediumReliance expanding caustic (6M→8M tons) with new European depots. Adani also expanding (~10M tons). These large, integrated players have cost advantages (scale, integration, access to chlorine end-use). Lords Chloro regional player in Alwar.
Specialty chemical diversification unproven
MediumCPW and future specialty chemicals are new products/revenue streams. CPW only 1.5 years into production, unproven at scale. Specialty chemical acquisitions/partnerships not yet identified. Management pursuing R&D via external research partner.
Management
Score 7/10. Transparent on challenges (acknowledged worst caustic quarter in long time). Detailed on operational metrics (tonnages, costs, renewable energy targets). But deferred ECU and CPW margin specifics to post-call (CFO follow-up). NDA-shield withheld customer names; didn't claim customer concentration risk. 21 MW solar commissioned on time (FY26 target met). Renewable energy 40% operational (tracking to guidance). Caustic volumes 9% YoY growth despite market headwinds. BUT: PAT down 40% QoQ despite cost control (raw material inflation + incentive payout offset gains).
1 · Jul 2026
New electrolyzer (360T capacity) operational, 9 months of sales in FY27
2 · Jun 2026
10 MW wind-solar grid contracts finalized, renewable power 70%-80%
3 · Q3 FY27
Paraffin oil price stabilization; CPW margin recovery as product matures
Near-term commodity headwinds dominate; long-term (2024-2026) diversification into specialty chemicals and renewable margin support offer upside if execution stays on track.
Revenue at record highs masks profit collapse as caustic realizations hit worst quarter in long time
Highest quarterly revenue ever at ₹115.4 Cr, but net profit crashed 40% QoQ to ₹9.0 Cr as caustic soda realizations collapsed. Cost inflation in raw materials and employee benefits overwhelmed renewable energy savings.
₹115.4 Cr
Highest ever; +17.3% YoY, +8.5% QoQ
₹9.0 Cr
Flat YoY; down 39.7% QoQ from ~₹15 Cr Q1
7.8%
vs 9.0% in Q2 FY26; margin compression 120 bps
Lords Chloro posted its highest quarterly revenue but profit imploded. The paradox cuts through the noise: caustic soda volumes grew 9% YoY to 23,000 tons, yet net profit flatlined year-over-year and crashed 40% from the prior quarter. Management's own phrase—"worst quarter in terms of caustic soda realizations in a very long time"—is the quarter in a single sentence. Despite holding market share and volume, prices fell so steeply that margin compression overwhelmed every operational gain.
Where the profit went
Three cost headwinds collided. Raw materials surged ₹6 Cr (paraffin oil inflation tied to US-Iran geopolitical tensions; sulfuric acid spikes from the same cause). Employee benefits jumped ₹8 Cr due to Diwali bonus and half-yearly incentive payouts—management frames this as non-recurring and says the baseline will reset to 4% going forward. That's ₹14 Cr in fresh cost. The renewable energy program—21 MW solar commissioned on schedule in Q2—saved ₹5 Cr in power costs, reducing exposure from ₹8.3 per unit on the grid to ₹2 per unit on renewable. The arithmetic is brutal: ₹14 Cr in inflation minus ₹5 Cr in savings = a net ₹9 Cr profit hit, explaining the 40% QoQ collapse from ~₹15 Cr in Q1 to ₹9 Cr in Q2.
The worst quarter in terms of caustic soda realizations in a very long time. So even though there were lower product realizations, we've managed to give similar numbers.
Highest revenue achieved, ₹115.4 Cr vs ₹100 Cr in Q2 FY26
Supported ✓Q2 FY27 ₹115.4 Cr; YoY growth +17.3%. Confirmed.
Caustic volumes 23,000 tons, up 9% YoY vs Q2 FY26 21,000 tons
Supported ✓23,000 ÷ 21,000 = 9.5% growth. Exact match to claimed 9% range.
Power cost savings ₹5 Cr QoQ from 21 MW solar commissioned mid-June
Supported ✓Power & fuel ₹37.79 Cr Q2 vs ₹42.79 Cr implied Q1. Delta ≈ ₹5 Cr. Now 47 MW total operational (40% of consumption).
Caustic realizations improved to negative 1,000–0 in Alwar region
Contradicted ✗Management acknowledged caustic worst quarter in long time; realizations down QoQ significantly despite same volumes.
What changed on this call
Caustic outlook reset. Prior guidance (FY26 calls) promised "positive momentum in caustic soda realizations driven by strong domestic demand and global commodity trends." Reality: worst quarter in a long time. This is a hard 180-degree reversal of tone. Renewable energy on schedule; target raised. 21 MW solar hit the mid-June FY26 target. Now 47 MW DC total operational covers 40% of consumption at ₹2/unit (vs grid ₹8.3, group captive ₹4.50). Management raised the long-term horizon to 70–80% renewable by 2025–26, contingent on Rajasthan policy allowing 25% contract procurement. CPW emerges as diversification bright spot. Chlorinated paraffin wax volumes surged 40% and now represent 40% of total production (100+ tons flakes, 150 tons open market, 100 tons captive use). At only 1.5 years into commercialization, the product has pricing power: paraffin oil cost inflation actually lifted CPW realizations. Company targets CPW and specialty chemicals at 20–25% of income by year 5. First specific FY27 full-year guidance. Revenue target ₹550 Cr (assumes 9 months of new 360T electrolyzer post-July 2026 commissioning). Quarterly EBITDA ₹15–20 Cr post-July. Capex ₹315 Cr total (₹150 done, ₹165 by July). Free cash flow ₹80+ Cr annually post-capex. These are quantified, narrow-band commitments—a step change from prior directional guidance.
Bull-bear ledger
Bull: Volume growth amid market headwinds. Caustic +9%, CPW +40% YoY. Gaining share in flat-to-down market.
Bull: Renewable energy execution proven. 47 MW live on schedule, now 40% of consumption. Cost ₹2/unit is a durable advantage.
Bull: New 360T plant (July 2026) capex on track. Incremental EBITDA ₹15–20 Cr/quarter at mid-point is ₹60+ Cr annualized.
Bull: Diversification pipeline emerging. CPW scaling faster than expected; specialty chemical R&D via external partner. Reduces commodity beta longer-term.
Bear: Caustic margin collapse to worst in long time. One-quarter data point, but severe.
Bear: Large-cap competition entering. Reliance scaling 6M→8M tons caustic, Adani ~10M tons. Supply glut will suppress pricing for years.
Bear: Cost inflation likely to persist. Paraffin oil and sulfuric acid tied to geopolitical risk (US-Iran). War premium could linger 12+ months.
Bear: Specialty diversification unproven. CPW is 1.5 years old. Future specialties at R&D stage. Execution risk is real.
Bear: Margin compression is structural, not cyclical. PAT flat YoY on 17% revenue growth. NPM fell 120 bps YoY.
Risks ranked by holder impact
Caustic realizations don't recover (supply glut from Reliance/Adani entry)
HighNew capacity (Reliance 6→8M, Adani ~10M tons) floods Indian market in 2025–2026. Supply glut could keep prices depressed for 2–3 years. Lords Chloro's freight premium (Alwar region ₹36–37K vs Gujarat ₹32–33K) is real but won't offset 10M+ ton glut.
Paraffin oil cost inflation persists (US-Iran tensions)
HighRaw materials up ₹6 Cr this quarter. If geopolitical friction lingers, commodity inflation stays. CPW margin range (0–20% depending on input costs) remains volatile. Profitability stays compressed.
New plant capex execution delays past July 2026
Medium₹165 Cr remaining capex due by July to commission 360T electrolyzer. Any slip pushes revenue and EBITDA into FY28. FY27 ₹550 Cr target misses; management credibility erodes.
Specialty chemical diversification fails to scale
MediumCompany targets 20–25% of income from CPW and unnamed specialty products by year 5. If CPW margins compress or future specialties don't gain traction, commodity exposure remains the driver. The diversification thesis is the bull case.
Rajasthan renewable energy policy change
Medium70–80% renewable target depends on Rajasthan permitting 25% contract procurement. Policy revert stalls renewable roadmap. Cost advantage (₹2 vs ₹8.3 grid) limited to current 47 MW rather than covering majority of consumption.
How the street is positioned
The market rejected the quarter. The stock fell 4.7% on day 1 post-result and continued sliding to -5.06% by day 3, signalling the market's verdict: profit miss trumps record revenue. Stock now trades ₹129.99, down 46.3% from its all-time high of ₹241.99 and below its 20-day (₹134.75), 50-day (₹137.34), and 200-day (₹137.03) moving averages. RSI sits neutral at 43.5. Valuation is punitive: a 46% drawdown from ATH on an earnings miss (PAT -40% QoQ) leaves no near-term re-rating catalyst visible. Ownership is heavily concentrated: promoter 74.97% (stable quarter-over-quarter), FII 0.01%, DII 0.07%. Institutional absence is stark—this is a family-run, promoter-controlled business with minimal institutional penetration. No bulk or block trades suggest insider selling near the highs; the drawdown appears to reflect general market sentiment on commodity exposure, not founder de-risking. For a holder, this ownership mix means limited downside from forced institutional selling but also limited upside from new flows if the stock re-accelerates. The stock is orphaned, waiting for proof of execution.
1 · Q3 caustic realization trend
Management guided that caustic hit a cyclical trough (worst quarter in long time). If Q3 stabilizes or marginal recovery, bears weaken. Further deterioration reprices for multi-year commodity down-cycle.
2 · July 2026 plant commissioning and EBITDA trajectory
Proof point on capex execution. Commissioning in July and post-July quarterly EBITDA ₹15–20 Cr validates guidance and unlocks market re-rating for FY28 upside.
3 · CPW margin stabilization and specialty M&A signals
CPW margins volatile (0–20% range) with paraffin swings. Stabilization to steady 10–15% range de-risks diversification thesis. Any named specialty chemical partnership or acquisition signals serious execution intent.
This quarter marks a reset, not a reckoning. Highest revenue ever, but profit down 40% QoQ. The company executed operationally (volume, renewable energy) but was swamped by commodity and cost headwinds. The market has rightly punished it (down 46% from ATH, -5% post-result), and fundamentals don't yet justify a bounce. But the long-term thesis lives: a capable operator building renewable cost advantage and emerging diversification. Neither has proven transformational. The number to track from here is quarterly PAT post-July. If management delivers on the ₹15–20 Cr quarterly EBITDA guidance once capex concludes, PAT should stabilize in the ₹11–14 Cr range, ending the margin deterioration story. That's the inflection point. Until then, the verdict stands: **Hold**.